95 related articles for article (PubMed ID: 8697663)
1. Severe necroziting vasculitis in a patient with hepatitis C virus infection treated by interferon.
Pateron D; Fain O; Sehonnou J; Trinchet JC; Beaugrand M
Clin Exp Rheumatol; 1996; 14(1):79-81. PubMed ID: 8697663
[TBL] [Abstract][Full Text] [Related]
2. [Hepatitis C and immunologic anomalies].
Lunel F
Gastroenterol Clin Biol; 1994; 18(10):829-38. PubMed ID: 7875390
[No Abstract] [Full Text] [Related]
3. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus.
Misiani R; Bellavita P; Fenili D; Vicari O; Marchesi D; Sironi PL; Zilio P; Vernocchi A; Massazza M; Vendramin G
N Engl J Med; 1994 Mar; 330(11):751-6. PubMed ID: 8107741
[TBL] [Abstract][Full Text] [Related]
4. Extrahepatic manifestations of chronic viral hepatitis.
Willson RA
Am J Gastroenterol; 1997 Jan; 92(1):3-17. PubMed ID: 8995930
[No Abstract] [Full Text] [Related]
5. [Vasculitis and liver disease].
Spangenberg HC; Blum HE
Praxis (Bern 1994); 2006 Oct; 95(40):1557-62. PubMed ID: 17048414
[TBL] [Abstract][Full Text] [Related]
6. Manifestation of cutaneous polyarteritis nodosa during interferon therapy for chronic hepatitis C associated with primary biliary cirrhosis.
Dohmen K; Miyamoto Y; Irie K; Takeshita T; Ishibashi H
J Gastroenterol; 2000; 35(10):789-93. PubMed ID: 11063225
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection with and without cryoglobulinemia as a case of Churg-Strauss syndrome.
Mercié P; Viallard JF; Faure I; Trimoulet P; Vital A; Lifermann F; Leng B; Pellegrin JL
J Rheumatol; 2000 Mar; 27(3):814-7. PubMed ID: 10743831
[TBL] [Abstract][Full Text] [Related]
8. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates.
Hartmann H; Schott P; Polzien F; Mihm S; Uy A; Kaboth U; Pardowitz I; Ramadori G
Z Gastroenterol; 1995 Nov; 33(11):643-50. PubMed ID: 8600660
[TBL] [Abstract][Full Text] [Related]
9. Polyarteritis nodosa after interferon treatment for chronic hepatitis C.
de Dios García-Díaz J; García-Sánchez M; Busteros JI; Arcos P
J Clin Virol; 2005 Feb; 32(2):181-2. PubMed ID: 15653424
[No Abstract] [Full Text] [Related]
10. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
[TBL] [Abstract][Full Text] [Related]
11. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis.
Rotondi M; Minelli R; Magri F; Leporati P; Romagnani P; Baroni MC; Delsignore R; Serio M; Chiovato L
Eur J Endocrinol; 2007 Apr; 156(4):409-14. PubMed ID: 17389454
[TBL] [Abstract][Full Text] [Related]
12. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Saadoun D; Limal N; Sene D; Lidove O; Piette JC
Arthritis Rheum; 2005 Mar; 52(3):911-5. PubMed ID: 15751068
[TBL] [Abstract][Full Text] [Related]
13. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.
Schvarcz R; Ando Y; Sönnerborg A; Weiland O
J Hepatol; 1995; 23 Suppl 2():17-21. PubMed ID: 8720289
[TBL] [Abstract][Full Text] [Related]
14. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
Bizollon T; Ducerf C; Trépo C
J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
[TBL] [Abstract][Full Text] [Related]
15. [Interferon-alpha and ribavirin treatment in a patient with hepatitis C virus-associated cutaneous periarteritis nodosa].
Naouri M; Bacq Y; Machet MC; Rogez C; Machet L
Ann Dermatol Venereol; 2006; 133(8-9 Pt 1):679-82. PubMed ID: 17053737
[TBL] [Abstract][Full Text] [Related]
16. Polyarteritis nodosa and mixed cryoglobulinaemia related to hepatitis B and C virus coinfection.
Garcia de La Peña Lefebvre P; Mouthon L; Cohen P; Lhote F; Guillevin L
Ann Rheum Dis; 2001 Nov; 60(11):1068-9. PubMed ID: 11602482
[TBL] [Abstract][Full Text] [Related]
17. Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa.
Carson CW; Conn DL; Czaja AJ; Wright TL; Brecher ME
J Rheumatol; 1993 Feb; 20(2):304-9. PubMed ID: 8097250
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
19. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis.
Mochida S; Ohnishi K; Matsuo S; Kakihara K; Fujiwara K
Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):371A-377A. PubMed ID: 8986241
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha therapy for hepatitis C virus recurrence after liver transplantation: long-term response with maintenance therapy.
Singh N; Gayowski T; Wannstedt CF; Marino IR; Wagener MM
Clin Transplant; 1996 Aug; 10(4):348-51. PubMed ID: 8884107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
